Loading
Rakovina Therapeutics Inc. - formerly, Vincero Capital Corp. Stock: price and insider trades · Canada
CA·Mcap CA$5.5M
Rakovina Therapeutics Inc. - formerly, Vincero Capital Corp.: what insiders have been doing
Rakovina Therapeutics Inc. - formerly, Vincero Capital Corp. is a listed company. Filings by its managers are published through SEDI. Over the twelve months to 18 October 2026, the company's managers filed 29 filings, from 7 insiders.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
No insider has bought Rakovina Therapeutics Inc. - formerly, Vincero Capital Corp. shares on the open market in the past twelve months.
Across the 2,126 companies tracked on its exchange, the median is 12 filings; at 29 filings, this issuer sits above that mark.
This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Insider Decl.
29
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended December 2025 · cache
CA$0.23
Analyst consensus
1 analystsCA$0.25Target CA$0.25(+11%)CA$0.25
Income statement
EBITDA-CA$7.7M
Net income-CA$8.7M0.0% margin
Valuation
P/Book35.7x
Beta-0.24
Balance sheet & cash
Market capCA$5.5M
Total debtCA$2.6M
Free Cash Flow-CA$5.8M
Profitability & ownership
ROE-1352.3%
ROA-79.6%
% insiders5.7%
% institutions0.0%
Last declaration on 14 October 2026
Declarations29 total
700,000 sharesWarrantsTSXSEDI:4791192
WarrantsTSXSEDI:4790742
500,000 sharesOptionsTSXSEDI:4780723
OptionsTSXSEDI:4780720
600,000 shares@ CA$0.202.14% mcap100.0% of flowOptionsTSXSEDI:4780381
300,000 shares@ CA$0.201.07% mcap100.0% of flowOptionsTSXSEDI:4779633
300,000 shares@ CA$0.201.07% mcap25.0% of flowOptionsTSXSEDI:4779632
OptionsTSXSEDI:4779630
75,000 shares@ CA$0.200.27% mcap100.0% of flowOptionsTSXSEDI:4779457
OptionsTSXSEDI:4779155
300,000 shares@ CA$0.201.07% mcap85.7% of flowOptionsTSXSEDI:4778916
WarrantsTSXSEDI:4769062
1,800,000 shares@ CA$0.103.22% mcap75.0% of flowCommon SharesTSXSEDI:4769061
Common SharesTSXSEDI:4769060
100,000 shares@ CA$0.100.18% mcap14.3% of flowCommon SharesTSXSEDI:4763702
2,430,000 sharesWarrantsTSXSEDI:4756480
2,700,000 sharesWarrantsTSXSEDI:4756478
Convertible DebenturesTSXSEDI:4756475
Convertible DebenturesTSXSEDI:4756469
17,100,000 sharesWarrantsTSXSEDI:4756468
19,000,000 shares@ CA$0.10WarrantsTSXSEDI:4756467
WarrantsTSXSEDI:4756466
17,100,000 sharesCommon SharesTSXSEDI:4756465
19,000,000 shares@ CA$0.05Common SharesTSXSEDI:4756464
Common SharesTSXSEDI:4756463
25 of 29 declarations
About Rakovina Therapeutics Inc. - formerly, Vincero Capital Corp.
Rakovina Therapeutics Inc., formerly Vincero Capital Corp., is a biotechnology company focused on developing innovative cancer treatments. It is listed on the XTSE.
